These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12021645)

  • 41. Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.
    Wiersinga W; Prummel MF
    J Clin Endocrinol Metab; 1995 Feb; 80(2):345-7. PubMed ID: 7852487
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Orbital radiation in Graves' disease.
    Rubenzik R
    Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740
    [No Abstract]   [Full Text] [Related]  

  • 43. Spontaneous medial orbital decompression associated with medial wall remodeling in Graves' orbitopathy.
    Detorakis ET
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):79-80. PubMed ID: 24398502
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
    Mourits MP
    Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
    [No Abstract]   [Full Text] [Related]  

  • 45. [Radiotherapy of endocrine orbitopathy--state of the art].
    Prettenhofer U; Ramschak-Schwarzer S; Langmann A; Mayer R; Schedlbauer P; Hackl A
    Acta Med Austriaca; 2001; 28(4):97-8. PubMed ID: 11593899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score.
    Le Moli R; Pluchino A; Muscia V; Regalbuto C; Luciani B; Squatrito S; Vigneri R
    Eur J Ophthalmol; 2012; 22(3):301-8. PubMed ID: 21786273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supervoltage orbital radiotherapy for Graves' ophthalmopathy.
    Donaldson SS; Bagshaw MA; Kriss JP
    J Clin Endocrinol Metab; 1973 Aug; 37(2):276-85. PubMed ID: 4198257
    [No Abstract]   [Full Text] [Related]  

  • 49. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response.
    Polito E; Leccisotti A
    Ophthalmologica; 1995; 209(4):182-6. PubMed ID: 8545089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy for Graves' ophthalmopathy: results at one year.
    Gorman CA
    Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 53. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
    Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Choice of neuroradiological methods in ophthalmology--the optic nerve, muscles of the eye and orbit].
    Bakke SJ; Kerty E
    Tidsskr Nor Laegeforen; 2001 Apr; 121(11):1361-4. PubMed ID: 11419105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Exp Clin Endocrinol; 1991 May; 97(2-3):332-7. PubMed ID: 1915652
    [No Abstract]   [Full Text] [Related]  

  • 56. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
    Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The initial clinical characteristics of Graves' orbitopathy vary with age and sex.
    Kendler DL; Lippa J; Rootman J
    Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Endocrinological findings in endocrine orbitopathy].
    Hädecke J; Schneyer U
    Klin Monbl Augenheilkd; 2005 Jan; 222(1):15-8. PubMed ID: 15678394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
    Pedrosa P; Pfannenstiel P; Just M; Higer HP; Utech C; Brederhoff J; Wulle KG
    Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.